Independent and combined influence of AGTR1 variants and aerobic exercise on oxidative stress in hypertensives

Blood Pressure

Volumn 18, Issue 4, 2009, Pages 204-212

  Fenty Stewart, Nicola ^a,b   Park, Joon Young ^a,c   Roth, Stephen M ^a   Hagberg, James M ^a   Basu, Samar ^d   Ferrell, Robert E ^e   Brown, Michael D ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UPPSALA UNIVERSITY   (Sweden)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AGTR1; Angiotensin II; Exercise; Isoprostanes; Oxidative stress

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; SUPEROXIDE DISMUTASE;

ADULT; AEROBIC EXERCISE; AGED; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; ALLELES; ANGIOTENSIN II; BLOOD PRESSURE; EXERCISE; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 70849091230     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050903118706     Document Type: Article

References (35)

1. Vaziri ND, Dicus M, Ho ND, Boroujerdi-Rad L, Sindhu RK. Oxidative stress and dysregulation of superoxide dismutase and NADPHoxidase in renal insufficiency. Kidney Int. 2003;63:179-185.
2. Zhou MS, Schulman IH, Raij L. Nitric oxide, angiotensin II, and hypertension. Semin Nephrol. 2004;24:366-378.
3. Lu H, Boustany-Kari CM, Daugherty A, Cassis LA. Angiotensin IIincreases adipose angiotensinogen expression. Am JPhysiol Endocrinol Metab. 2007;292:E1280-E1287.
4. Malhotra R, Sadoshima J, Brosius FCIII, Izumo S. Mechanical stretch and angiotensin IIdifferentially upregulate the renin-angiotensin system in cardiac myocytes in vitro. Circ Res. 1999;85:137-146.
5. Terebessy T, Masszi A, Fintha A, Sebe A, Huszar T, Rosivall L, Mucsi I. Angiotensin IIactivates the human renin promoter in an in vitro model: the role of c-Jun-N-terminal kinase. Nephrol Dial Transplant. 2004; 19:2184-2191.
6. Rajagopalan S, kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPHoxidase activation. Contribution to alterations of vasomotor tone. JClin Invest. 1996;97:1916-1923.
7. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin IIin vascular smooth muscle cells. Pharmacol Rev. 2000;52:639-672.
8. Nickenig G, Harrison DG. The AT( 1)-type angiotensin receptor in oxidative stress and atherogenesis. Part I: oxidative stress and atherogenesis. Circulation. 2002;105:393-396. (Pubitemid 34106191)
9. Erdmann J, Riedel K, Rohde K, Folgmann I, Wienker T, Fleck E, Regitz-Zagrosek V. Characterization of polymorphisms in the promoter of the human angiotensin IIsubtype 1 (AT1) receptor gene. Ann Hum Genet. 1999;63(Pt4):369-374.
10. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin IItype 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 1994;24:63-69.
11. Sugimoto K, katsuya T, Ohkubo T, Hozawa A, Yamamoto K, Matsuo A, et al. Association between angiotensin IItype 1 receptor gene polymorphism and essential hypertension: The Ohasama Study. Hypertens Res. 2004;27:551-556.
12. Cameron VA, Mocatta TJ, Pilbrow AP, Frampton CM, Troughton RW, Richards AM, et al. Angiotensin type-1 receptor A1166Cgene polymorphism correlates with oxidative stress levels in human heart failure. Hypertension. 2006;47:1155-1161.
13. Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, et al. The human angiotensin IItype 1 receptor-1166 A/Cpolymorphism attenuates microrna-155 binding. JBiol Chem. 2007;282:24262-24269.
14. Jin W, Liu Y, Sheng HH, Jin L, Shen YY, Hua Q, et al. Single nucleotide polymorphisms in promoter of angiotensin IItype 1 receptor gene associated with essential hypertension and coronary heart disease in Chinese population. Acta Pharmacol Sin. 2003;24:1083-1088.
15. Poirier O, Georges JL, Ricard S, Arveiler D, Ruidavets JB, Luc G, et al. New polymorphisms of the angiotensin IItype 1 receptor gene and their associations with myocardial infarction and blood pressure: The ECTIMstudy. Etude Cas-Temoin de l'Infarctus du Myocarde. JHypertens. 1998;16:1443-1447.
16. Hagberg JM, Park JJ, Brown MD. The role of exercise training in the treatment of hypertension: an update. Sports Med. 2000;30:193-206.
17. Baster T, Baster-Brooks C. Exercise and hypertension. Aust Fam Physician. 2005;34:419-424.
18. Elosua R, Molina L, Fito M, Arquer A, Sanchez-Quesada JL, Covas MI, et al. Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physicalactivity, in healthy young men and women. Atherosclerosis. 2003;167:327-334.
19. American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription. Baltimore, MD: Lippincott Williams & Wilkins; 2000.
20. ChobanianAV, Bakris GL, BlackHR, Cushman WC, Green LA, Izzo JLJr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
21. Nicklas BJ, Rogus EM, Colman EG, Goldberg AP. Visceral adiposity, increased adipocyte lipolysis, and metabolic dysfunction in obese postmenopausal women. Am JPhysiol. 1996;270(1Pt1):E72-E78.
22. Seals DR, Hagberg JM, Hurley BF, Ehsani AA, Holloszy JO. Endurance training in older men and women. I. Cardiovascular responses to exercise. JAppl Physicol. 1984;57:1024-1029.
23. Basu S. The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target. Scand JFood Nutrition. 2007;51:48-61.
24. Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids. 1998;58:319-325.
25. Jiang Z, Zhao W, Yu F, Xu G. Association of angiotensin IItype 1 receptor gene polymorphism with essential hypertension. Chin Med J(Engl). 2001;114:1249-1251.
26. Jones A, Dhamrait SS, Payne JR, Hawe E, Li P, Toor IS, Luong L, et al. Genetic variants of angiotensin IIreceptors and cardiovascular risk in hypertension. Hypertension. 2003;42:500-506.
27. Watanabe T, Barker TA, Berk BC. Angiotensin IIand the endothelium: diverse signals and effects. Hypertension. 2005;45:163-169.
28. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS. Effects of ANGIItype 1 and 2 receptors on oxidative stress, renal NADPHoxidase, and SODexpression. Am JPhysiol Regul Integr Comp Physiol. 2003;285:R117-R124.
29. Ormezzano O, Cracowski JL, Mallion JM, Poirier O, Bessard J, Briancon S, et al. F2-Isoprostane level is associated with the angiotensin IItype 1 receptor -153A/Ggene polymorphism. Free Radic Biol Med. 2005;38:583-588.
30. Ohta M, Nanri H, Matsushima Y, Sato Y, Ikeda M. Blood pressure-lowering effects of lifestyle modification: possible involvement of nitric oxide bioavailability. Hypertens Res. 2005;28:779-786.
31. Roberts CK, Vaziri ND, Barnard RJ. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation. 2002; 106:2530-2532.
32. Kadiiska MB, Gladen BC, Baird DD, Germolec D,Graham LB, Parker CE, et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med. 2005;38:698-710.
33. Park JY, Ferrell RE, Park JJ, Hagberg JM, Phares DA, Jones JM, Brown MD. NADPH oxidase p22phox gene variants are associated with systemic oxidative stress biomarker responses to exercise training. JAppl Physiol. 2005;99:1905-1911.
34. Goto C, Higashi Y, kimura M, Noma K, Hara K, Nakagawa K, et al. Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress. Circulation. 2003; 108:530-535. (Pubitemid 36961165)
35. Bergholm R, Makimattila S, Valkonen M, Liu ML, Lahdenpera S, Taskinen MR, et al. Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo. Atherosclerosis. 1999;145:341-349.